The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia
Authors:
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective studyJournal of Translational Medicine, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Regulation of Endothelial Cell Adhesion Molecule Expression by Mast Cells, Macrophages, and NeutrophilsPLOS ONE, 2011
- Vascular Endothelial Growth Factor in Severe Sepsis and Septic ShockAnesthesia & Analgesia, 2008
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- Serum Soluble ICAM-1, VCAM-1, L-Selectin, and P-Selectin Levels as Markers of Infection and their Relation to Clinical Severity in Neonatal SepsisAmerican Journal of Perinatology, 2007
- Circulating Soluble Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 in Immunocompetent and Renal Transplant Patients: Correlation with Cytomegalovirus Disease and Renal FunctionScandinavian Journal of Infectious Diseases, 2001
- Increases of sICAM-1 during neutropenic pneumonia in leukemic patientsLeukemia, 1997
- Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndromeCritical Care Medicine, 1994
- Role of intercellular adhesion molecule-1 in the inflammatory responseKidney International, 1992